Pharmaceutical giant Johnson & Johnson (J&J) has reported a stronger-than-expected second-quarter earnings performance. The company’s chief financial officer stated that it can pursue any acquisition deal it desires.
In a quarterly earnings conference call, J&J announced revenue of $25.9 billion and net income of $4.5 billion. This surpassed analyst estimates by a significant margin.
The CFO acknowledged that Johnson & Johnson is prepared to consider any potential merger or acquisition opportunities. The company’s strong financial position and diverse portfolio make it an attractive target for other businesses.
Source: https://www.barrons.com/articles/johnson-jnj-earnings-stock-price-e403b4d0